HomeCompareSAUHY vs MRK

SAUHY vs MRK: Dividend Comparison 2026

SAUHY yields 2.03% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SAUHY wins by $151.4K in total portfolio value· pulled ahead in Year 5
10 years
SAUHY
SAUHY
● Live price
2.03%
Share price
$10.32
Annual div
$0.21
5Y div CAGR
57.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$208.2K
Annual income
$102,257.93
Full SAUHY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SAUHY vs MRK

📍 SAUHY pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSAUHYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SAUHY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SAUHY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAUHY
Annual income on $10K today (after 15% tax)
$172.97/yr
After 10yr DRIP, annual income (after tax)
$86,919.24/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SAUHY beats the other by $78,590.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAUHY + MRK for your $10,000?

SAUHY: 50%MRK: 50%
100% MRK50/50100% SAUHY
Portfolio after 10yr
$132.5K
Annual income
$56,028.03/yr
Blended yield
42.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SAUHY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
8.9
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAUHY buys
0
MRK buys
0
No recent congressional trades found for SAUHY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSAUHYMRK
Forward yield2.03%2.76%
Annual dividend / share$0.21$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR57.4%32.7%
Portfolio after 10y$208.2K$56.8K
Annual income after 10y$102,257.93$9,798.13
Total dividends collected$177.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: SAUHY vs MRK ($10,000, DRIP)

YearSAUHY PortfolioSAUHY Income/yrMRK PortfolioMRK Income/yrGap
1$11,020$320.29$11,206$366.19$186.00MRK
2$12,311$519.23$12,650$502.35$339.00MRK
3$14,026$853.25$14,407$694.19$381.00MRK
4$16,438$1,430.01$16,585$967.82$147.00MRK
5← crossover$20,054$2,465.31$19,342$1,363.89+$712.00SAUHY
6$25,882$4,424.30$22,913$1,947.19+$3.0KSAUHY
7$36,093$8,399.71$27,662$2,823.89+$8.4KSAUHY
8$55,851$17,231.25$34,159$4,173.35+$21.7KSAUHY
9$98,984$39,223.20$43,337$6,308.80+$55.6KSAUHY
10$208,171$102,257.93$56,776$9,798.13+$151.4KSAUHY

SAUHY vs MRK: Complete Analysis 2026

SAUHYStock

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Full SAUHY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SAUHY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAUHY vs SCHDSAUHY vs JEPISAUHY vs OSAUHY vs KOSAUHY vs MAINSAUHY vs JNJSAUHY vs ABBVSAUHY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.